Centro de Investigación Clínica de Oaxaca - Oaxaca
El Centro de investigación Clínica de Oaxaca, es una institución que ofrece la conducción de estudios clínicos patrocinados, beneficiando con tratamiento innovadores la calidad de vida de los pacientes en nuestro estado, salvaguardando en todo momento la integridad y autonomía de ellos, de la misma manera a las farmacéuticas el cumplimiento de sus objetivos con apego a los lineamientos nacionales e internacionales.Carretera a San Luis Beltrán No.112. Col. Jardín, Oaxaca
Select an option
I am a doctor
I am a sponsor
Specializations
Cáncer de mama
Oncología
Neumología
Hematología
Cardiología
Our team
Medical staff
Roberto Iván Romero Díaz
Yolanda Lizbeth Bautista Aragon
Graciela Yescas Sosa
Gabriel Barragán Ibáñez
Jesús Antonio Pérez Ríos
Carlos Castro
Roberto Castro
Open studies
Breast Cancer
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy - Astefania - Hoffmann-La RocheSee more
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer - EMBER-4 - Eli Lilly and CompanySee more
A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer - Hoffmann-La RocheSee more
A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants - SUMIT-BC - Carrick Therapeutics LimitedSee more
Esophageal cancer
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers - HERIZON-GEA-01 - Zymeworks Inc.See more
Gastric cancer
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers - HERIZON-GEA-01 - Zymeworks Inc.See more
Gastroesophageal cancer
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers - HERIZON-GEA-01 - Zymeworks Inc.See more
Myeloproliferative syndromes
Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis - Kartos Therapeutics, Inc.See more
